Overview
Yi-fei Cheng practices in Beijing, China. Ms. Cheng is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Her top areas of expertise are Aplastic Anemia, Graft Versus Host Disease (GvHD), Acute Lymphoblastic Leukemia (ALL), Leukemia, and Bone Marrow Transplant.
Her clinical research consists of co-authoring 60 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Acute Megakaryoblastic Leukemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Aplastic AnemiaMs. Cheng isAdvanced. Learn about Aplastic Anemia.
- Bone Marrow TransplantMs. Cheng isAdvanced. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)
- LeukemiaMs. Cheng isAdvanced. Learn about Leukemia.
- Experienced
- ABO IncompatibilityMs. Cheng isExperienced. Learn about ABO Incompatibility.
- Acute Megakaryoblastic LeukemiaMs. Cheng isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myeloid Leukemia (AML)Ms. Cheng isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaMs. Cheng isExperienced. Learn about Adult T-Cell Leukemia.
- AnemiaMs. Cheng isExperienced. Learn about Anemia.
- Bronchiolitis ObliteransMs. Cheng isExperienced. Learn about Bronchiolitis Obliterans.